Progress in molecular mechanisms of tumor metastasis and angiogenesis

Antonina Harlozinska1

  • 1Department of Clinical Immunology, Wroclaw Medical University, Wroclaw, Poland. aharloz@immuno.am.wroc.pl

Anticancer Research
|August 17, 2005
PubMed

Insights

Metastasis, the primary cause of cancer death, involves complex cell interactions and microenvironment factors. Understanding these molecular mechanisms is key to developing new anticancer treatments.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Metastasis is the leading cause of cancer mortality, yet its underlying mechanisms remain incompletely understood.
  • Recent advances have illuminated the intricate molecular and cellular processes governing tumor metastasis, focusing on cancer cell and organ microenvironment interactions.

Purpose of the Study:

  • To review the current knowledge on the molecular and cellular mechanisms of tumor invasion and metastasis.
  • To discuss the role of the tumor microenvironment and phenotype in metastatic site predilection.
  • To summarize insights into angiogenesis and tumor cell dissemination.

Main Methods:

  • Literature review of recent reports on tumor metastasis.
  • Analysis of molecular and cellular processes including cell adhesion, migration, and proteolysis.
  • Discussion of the interplay between genetic/epigenetic events and metastasis.

Main Results:

  • Tumor invasion involves a three-step process: cell attachment, local proteolysis, and cell migration.
  • Cell-cell adhesions, cell-matrix interactions, proteolysis, and migration properties are critical for invasion.
  • Metastatic capacity may be acquired early in tumorigenesis, potentially predicting metastatic sites.

Conclusions:

  • A comprehensive understanding of metastasis mechanisms, including tumor phenotype and microenvironment interactions, is crucial.
  • Further research into the genetic and epigenetic factors driving metastasis can inform novel therapeutic strategies.
  • Targeting molecular pathways involved in invasion, dissemination, and angiogenesis holds promise for future cancer treatments.

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...